Opsonising Antibodies to P. falciparum Merozoites Associated with Immunity to Clinical Malaria

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Hill, Danika L ^a,b   Eriksson, Emily M ^a,b   Li Wai Suen, Connie S N ^a,b   Chiu, Chris Y ^a,b   Ryg Cornejo, Victoria ^a,b   Robinson, Leanne J ^a,c   Siba, Peter M ^c   Mueller, Ivo ^a,b,d   Hansen, Diana S ^a   Schofield, Louis ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL POPULATION; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LIMIT OF DETECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MEROZOITE; NATURAL KILLER CELL; OPSONIZATION; PARASITEMIA; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL LINE; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, HUMORAL; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MONOCYTES; OPSONIN PROTEINS; PAPUA NEW GUINEA; PARASITEMIA; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; REPRODUCIBILITY OF RESULTS;

EID: 84883606588     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074627     Document Type: Article

References (47)

1. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, et al. (2012) Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. The Lancet 379: 1960-1966 doi:10.1016/S0140-6736(12)60484-X.
2. Trape J-F, Tall A, Diagne N, Ndiath O, Ly AB, et al. (2011) Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis 11: 925-932 doi:10.1016/S1473-3099(11)70194-3.
3. malERA Consultative Group on Vaccines (2011) A research agenda for malaria eradication: vaccines. Plos Med 8: e1000398 doi:10.1371/journal.pmed.1000398.
4. Marsh K, Kinyanjui S, (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60 doi:10.1111/j.1365-3024.2006.00808.x.
5. Cohen S, McGregor IA, Carrington S, (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
6. McGregor IA, (1964) THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY. Am J Trop Med Hyg 13: SUPPL237-SUPPL239.
7. Calle JM, Nardin EH, Clavijo P, Boudin C, Stüber D, et al. (1992) Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. J Immunol 149: 2695-2701.
8. Mendis KN, David PH, Carter R, (1990) Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines. Int J Parasitol 20: 497-502.
9. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, et al. (2002) A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J INFECT DIS 185: 820-827 doi:10.1086/339342.
10. Sirima SB, Cousens S, Druilhe P, (2011) Protection against malaria by MSP3 candidate vaccine. N Engl J Med 365: 1062-1064 doi:10.1056/NEJMc1100670.
11. Fowkes FJI, Richards JS, Simpson JA, Beeson JG, (2010) The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. Plos Med 7: e1000218 doi:10.1371/journal.pmed.1000218.
12. Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, et al. (2008) Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Malar J 7: 142 doi:10.1186/1475-2875-7-142.
13. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, et al. (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24: 4233-4246 doi:10.1016/j.vaccine.2005.06.030.
14. Stanisic DI, Richards JS, Mccallum FJ, Michon P, King CL, et al. (2009) Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness. Infect Immun 77: 1165-1174 doi:10.1128/IAI.01129-08.
15. Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, et al. (2007) Profiling the Antibody Immune Response against Blood Stage Malaria Vaccine Candidates. Clinical Chemistry 53: 1244-1253 doi:10.1373/clinchem.2006.081695.
16. Lunel F, Descamps-Latscha B, Druilhe P, (1990) Activation of phagocyte oxidative metabolism by opsonized Plasmodium falciparum merozoites. Acta Trop 47: 61-68.
17. Khusmith S, Druilhe P, Gentilini M, (1982) Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun 35: 874-879.
18. Bouharoun-Tayoun H, Attanath P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P, (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172: 1633-1641.
19. Joos C, Marrama L, Polson HEJ, Corre S, Diatta A-M, et al. (2010) Clinical Protection from Falciparum Malaria Correlates with Neutrophil Respiratory Bursts Induced by Merozoites Opsonized with Human Serum Antibodies. PLoS ONE 5: e9871 doi:10.1371/journal.pone.0009871.t003.
20. Greve B, Kremsner PG, Lell B, Luckner D, Schmid D, (2000) Malarial anaemia in African children associated with high oxygen-radical production. Lancet 355: 40-41.
21. Druilhe P, Khusmith S, (1987) Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun 55: 888-891.
22. Oeuvray C, Bouharoun-Tayoun H, Gras-Masse H, Bottius E, Kaidoh T, et al. (1994) Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood 84: 1594-1602.
23. Theisen M, Soe S, Oeuvray C, Thomas AW, Vuust J, et al. (1998) The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun 66: 11-17.
24. Bélard S, Issifou S, Hounkpatin AB, Schaumburg F, Ngoa UA, et al. (2011) A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children. PLoS ONE 6: e22525 doi:10.1371/journal.pone.0022525.t004.
25. Hill DL, Eriksson EM, Carmagnac AB, Wilson DW, Cowman AF, et al. (2012) Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites. PLoS ONE 7: e51692 doi:10.1371/journal.pone.0051692.
26. Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, et al. (2007) The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 76: 997-1008.
27. McNamara DT, Kasehagen LJ, Grimberg BT, Cole-Tobian J, Collins WE, et al. (2006) Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am J Trop Med Hyg 74: 413-421.
28. Richards JS, Stanisic DI, Fowkes FJI, Tavul L, Dabod E, et al. (2010) Association between Naturally Acquired Antibodies to Erythrocyte-Binding Antigens of Plasmodium falciparumand Protection from Malaria and High-Density Parasitemia. CLIN INFECT DIS 51: e50-e60 doi:10.1086/656413.
29. Reiling L, Richards JS, Fowkes FJI, Barry AE, Triglia T, et al. (2010) Evidence That the Erythrocyte Invasion Ligand PfRh2 is a Target of Protective Immunity against Plasmodium falciparum Malaria. The Journal of Immunology 185: 6157-6167 doi:10.4049/jimmunol.1001555.
30. Reiling L, Richards JS, Fowkes FJI, Wilson DW, Chokejindachai W, et al. (2012) The Plasmodium falciparum Erythrocyte Invasion Ligand Pfrh4 as a Target of Functional and Protective Human Antibodies against Malaria. PLoS ONE 7: e45253 doi:10.1371/journal.pone.0045253.t005.
31. Wilson DW, Fowkes FJI, Gilson PR, Elliott SR, Tavul L, et al. (2011) Quantifying the Importance of MSP1-19 as a Target of Growth-Inhibitory and Protective Antibodies against Plasmodium falciparum in Humans. PLoS ONE 6: e27705 doi:10.1371/journal.pone.0027705.t002.
32. Saul A, (1987) Kinetic constraints on the development of a malaria vaccine. Parasite Immunol 9: 1-9.
33. Boyle MJ, Wilson DW, Richards JS, Riglar DT, Tetteh KKA, et al. (2010) Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proceedings of the National Academy of Sciences 107: 14378-14383 doi:10.1073/pnas.1009198107.
34. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K, (2007) IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 6: 82 doi:10.1186/1475-2875-6-82.
35. Fowkes FJ, Mcgready R, Cross NJ, Hommel M, Simpson JA, et al. (2012) New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women. J INFECT DIS: 1-10. doi:10.1093/infdis/jis566.
36. Akpogheneta OJ, Duah NO, Tetteh KKA, Dunyo S, Lanar DE, et al. (2008) Duration of Naturally Acquired Antibody Responses to Blood-Stage Plasmodium falciparum Is Age Dependent and Antigen Specific. Infect Immun 76: 1748-1755 doi:10.1128/IAI.01333-07.
37. Males S, Gaye O, Garcia A, (2008) Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children. CLIN INFECT DIS 46: 516-522 doi:10.1086/526529.
38. McIntosh RS, Shi J, Jennings RM, Chappel JC, de Koning-Ward TF, et al. (2007) The importance of human FcgammaRI in mediating protection to malaria. PLoS Pathog 3: e72 doi:10.1371/journal.ppat.0030072.
39. Jafarshad A, Dziegiel MH, Lundquist R, Nielsen LK, Singh S, et al. (2007) A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol 178: 3099-3106.
40. Tebo AE, Kremsner PG, Luty AJF, (2002) Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol 130: 300-306.
41. Goh YS, Grant AJ, Restif O, Mckinley TJ, Armour KL, et al. (2011) Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells. Immunology 133: 74-83 doi:10.1111/j.1365-2567.2011.03411.x.
42. Dugast A-S, Tonelli A, Berger CT, Ackerman ME, Sciaranghella G, et al. (2011) Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals. Virology 415: 160-167 doi:10.1016/j.virol.2011.03.012.
43. D'ombrain MC, Robinson LJ, Stanisic DI, Taraika J, Bernard N, et al. (2008) Association of Early Interferon-γ Production with Immunity to Clinical Malaria: A Longitudinal Study among Papua New Guinean Children. CLIN INFECT DIS 47: 1380-1387 doi:10.1086/592971.
44. Robinson LJ, D'ombrain MC, Stanisic DI, Taraika J, Bernard N, et al. (2009) Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New Guinea. Infect Immun 77: 3033-3043 doi:10.1128/IAI.00211-09.
45. D'ombrain MC, Hansen DS, Simpson KM, Schofield L, (2007) γδ-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-γ response to Plasmodium falciparum malaria. Eur J Immunol 37: 1864-1873 doi:10.1002/eji.200636889.
46. Hansen DS, Schofield L, (2004) Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int J Parasitol 34: 15-25 doi:10.1016/j.ijpara.2003.09.007.
47. Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, et al. (2008) Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells. Proc Natl Acad Sci USA 105: 14509-14514 doi:10.1073/pnas.0806727105.